Diabetes is one of the Australian Government's National Health Priority Areas. It is a significant and increasing health issue in this country, which poses a considerable burden to patients, healthcare professionals and healthcare resources.
The Pharmaceutical Alliance conducted independent research1 with medical practitioners to uncover just how complex and difficult diabetes can be to manage - both for patients and healthcare professionals. To gain an understanding of the barriers to achieving the recognised targets, qualitative research was carried out in two stages:
The research highlighted the very real difficulties medical practitioners face every day in managing type 2 diabetes, split across five key barriers:
To download a full copy of the report click here
The outcomes of this research prompted the development of DAVETM, a unique state-of-the-art EDSS (Electronic Decision Support System).
Developed in partnership with GPs, diabetes experts and Diabetes Australia, DAVETM helps healthcare professionals successfully complete the complex reviews and decision-making processes for type 2 diabetes patients within the time constraints of a consult. Based on the latest clinical guidelines, it ultimately promotes the provision of effective, evidence-based diabetes management plans.
DAVETM allows GPs, for the first time, to clearly review the relevant clinical data for their type 2 diabetes patients as well as assess their overall health status and relevant health issues. Based on the latest clinical guidelines, it promotes the provision of effective evidence-based diabetes management plans and allows the practitioner to facilitate a thorough, interactive, yet efficient consultation based on latest clinical evidence.
The DAVETM software links effectively with existing clinical record systems enabling the data to be read from, and recorded back into, the core GP system. The tool brings all the critical information together in an easy-to-review format to help GPs and practice nurses proactively monitor their patient's health status and progress to clinical treatment goals.
Feedback from our users has been that it's like having a 'third person' in the patient consultation - one that helps the consultation be thorough, interactive yet efficient.
The work of The Pharmaceutical Alliance is focused on maximising every interaction GPs have with their type 2 diabetes patients to achieve greater control of this complex chronic disease and reduce associated health complications, and ultimately maintain or improve the patient's quality of life.
Research shows Electronic Decision Support Systems contribute to improved quality and safety of healthcare and better patient outcomes2. The software tool will be one of the first healthcare software systems for management of a chronic disease to be independently evaluated, on both a qualitative and quantitative level.